Confirmatory study of TRK-820, kappa opioid receptor agonist, against pruritus resistant to the currently available treatment in hemodialysis patients

被引：0
|
作者：
Takamori, Kenji
Kumagai, Hiroo
Ebata, Toshiya
Muramatsu, Taro
Nakamoto, Hidetomo
Suzuki, Hiromichi
机构：
[1] Juntendo Univ, Urayasu Hosp, Dept Dermatol, Chiba, Japan
[2] Natl Def Med Coll, Dept Internal Med 2, Saitama, Japan
[3] Chitofuna Dermatol Clin, Tokyo, Japan
[4] Keio Univ, Sch Med, Dept Psychiat, Tokyo, Japan
[5] Saitama Med Univ Hosp, Dept Renal Med, Saitama, Japan
来源：
ACTA DERMATO-VENEREOLOGICA | 2007年 / 87卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
OP15
引用
收藏
页码：465 / 465
页数：1
相关论文
共 24 条
  • [1] Antipruritic activity of the κ-opioid receptor agonist, TRK-820
    Togashi, Y
    Umeuchi, H
    Okano, K
    Ando, N
    Yoshizawa, Y
    Honda, T
    Kawamura, K
    Endoh, T
    Utsumi, J
    Kamei, J
    Tanaka, T
    Nagase, H
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2002, 435 (2-3) : 259 - 264
  • [2] Effect of TRK-820, a selective kappa opioid receptor agonist, an rat schizophrenia model
    Yoshikawa, Satoru
    Ikeda, Ken
    Hareyama, Nana
    Kurokawa, Takahiro
    Nakao, Kaoru
    Mochizuki, Hidenori
    Ichinose, Hiroshi
    [J]. NEUROSCIENCE RESEARCH, 2008, 61 : S129 - S129
  • [3] Effects of TRK-820, a selective kappa opioid receptor agonist, on rat schizophrenia models
    Yoshikawa, Satoru
    Hareyama, Nana
    Ikeda, Ken
    Kurokawa, Takahiro
    Nakajima, Mayumi
    Nakao, Kaoru
    Mochizuki, Hidenori
    Ichinose, Hiroshi
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2009, 606 (1-3) : 102 - 108
  • [4] Potent antinociceptive effects of TRK-820, a novel κ-opioid receptor agonist
    Endoh, T
    Matsuura, H
    Tajima, A
    Izumimoto, N
    Tajima, C
    Suzuki, T
    Saitoh, A
    Suzuki, T
    Narita, M
    Tseng, L
    Nagase, H
    [J]. LIFE SCIENCES, 1999, 65 (16) : 1685 - 1694
  • [5] Syntheses of potential metabolites of a potent κ-opioid receptor agonist, TRK-820
    Kawamura, K
    Horikiri, H
    Hayakawa, J
    Seki, C
    Yoshizawa, K
    Umeuchi, H
    Nagase, H
    [J]. CHEMICAL & PHARMACEUTICAL BULLETIN, 2004, 52 (06) : 670 - 674
  • [6] Effects of a novel kappa opioid receptor agonist, TRK-820, on intrathecal morphine-induced itch and analgesia in monkeys
    Ko, Mei-Chuan
    Husbands, Stephen
    [J]. FASEB JOURNAL, 2008, 22
  • [7] A novel κ-opioid receptor agonist, TRK-820 blocks the development of physical dependence on morphine in mice
    Tsuji, M
    Takeda, H
    Matsumiya, T
    Nagase, H
    Yamazaki, M
    Narita, M
    Suzuki, T
    [J]. LIFE SCIENCES, 2000, 66 (25) : PL353 - PL358
  • [8] Topical TRK-820 (Nalfurafine), a kappa-opioid receptor agonist, suppresses scratching and inflammatory changes in oxazolone challenged mouse ears
    Elliott, G.
    Soeberdt, M.
    Vanwersch, R.
    Metze, D.
    Lotts, T.
    Staender, S.
    Abels, C.
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2015, 135 : S9 - S9
  • [9] Effect of repeated administration of TRK-820, a κ-opioid receptor agonist, on tolerance to its antinociceptive and sedative actions
    Suzuki, T
    Izumimoto, N
    Takezawa, Y
    Fujimura, M
    Togashi, Y
    Nagase, H
    Tanaka, T
    Endoh, T
    [J]. BRAIN RESEARCH, 2004, 995 (02) : 167 - 175
  • [10] Anti-pruritic effect of a kappa opioid receptor agonist TRK-820.
    Umeuchi, H
    Tanaka, T
    Kawamura, K
    Okano, K
    Endoh, T
    Kamei, J
    Nagase, H
    [J]. JOURNAL OF PHARMACOLOGICAL SCIENCES, 2003, 91 : 198P - 198P
123